NCT02440997

Brief Summary

The purpose of this study is to preliminarily establish the extent to which a brief aromatherapy intervention incrementally improves subjective and objective indicators of discomfort (pain, anxiety, and heart rate variability) beyond passive relaxation in youth with chronic headaches. A secondary objective is to establish the safety of using aromatherapy as a treatment strategy in youth with chronic headache. The investigators hypothesize that children randomized to the aromatherapy condition will demonstrate a greater improvement in pain, anxiety, and objectively measured distress (heart rate variability) than comparable children receiving only a passive relaxation treatment (a foot bath). The investigators further hypothesize that the aromatherapy intervention will be safe and well-tolerated by study participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 25, 2015

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 12, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 4, 2017

Completed
Last Updated

April 10, 2017

Status Verified

April 1, 2017

Enrollment Period

1.8 years

First QC Date

April 22, 2015

Last Update Submit

April 7, 2017

Conditions

Keywords

aromatherapy, peppermint

Outcome Measures

Primary Outcomes (2)

  • improvement in subjective and objective indicators of discomfort

    pain and anxiety measured subjectively via VAS

    30 minutes

  • improvement in subjective and objective indicators of discomfort

    heart rate variability measured -10, 10 and 20 minutes

    30 minutes

Secondary Outcomes (1)

  • number of Adverse Events

    30 minutes

Study Arms (2)

foot bath only

PLACEBO COMPARATOR

10 minute foot bath with addition of jojoba only

Other: foot bath

foot bath and aromatherapy

EXPERIMENTAL

10 minute foot bath with addition of jojoba with added Mentha piperita

Other: aromatherapyOther: foot bath

Interventions

Also known as: Mentha piperita
foot bath and aromatherapy
foot bath and aromatherapyfoot bath only

Eligibility Criteria

Age7 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Male or female, children and adolescents age 7-17 years of age
  • Diagnosed with status migrainosus or refractory chronic daily headache according to the International Headache Society (ICHD-II) criteria. (A debilitating migraine lasting for more than 72 hours or a headache that lasts hours or may be continuous occurring on \> 15 days per month for \> 3 months.)
  • No prior history of aromatherapy / essential oil use
  • Able to read, comprehend and complete study procedures. Capable of reading and completing all subjective measures in English
  • Are sufficiently alert to be assessed and communicate
  • Must be compliant with routine medical care and able to perform study-related procedures
  • Provide written informed consent from parent/legal guardian and child assent in accordance with IRB regulations

You may not qualify if:

  • Known sensitivity to essential oils
  • History of cardiac fibrillation
  • History of G6PD deficiency
  • History of uncontrolled asthma (current, active wheezing)
  • History of diabetes, high blood pressure, epilepsy,
  • Inflammatory or sensory limitations of lower extremities or concurrent lesions of the foot(s)
  • Past or concurrent history of olfactory impairment
  • Concomitant use of propanolol
  • Tobacco use
  • Hepatotoxicity
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Mercy Hospital

Kansas City, Missouri, 64108, United States

Location

Related Publications (32)

  • Battaiglia, S. (2003). The complete guide to aromatherapy (2nd edition). Brisbane, Australia: The International Centre of Holistic Aromatherapy

    BACKGROUND
  • Blume HK. Pediatric headache: a review. Pediatr Rev. 2012 Dec;33(12):562-76. doi: 10.1542/pir.33-12-562. No abstract available.

    PMID: 23204398BACKGROUND
  • Buckle J. Use of aromatherapy as a complementary treatment for chronic pain. Altern Ther Health Med. 1999 Sep;5(5):42-51.

    PMID: 10484830BACKGROUND
  • Fitzgerald M, Culbert T, Finkelstein M, Green M, Liu M. The effect of gender and ethnicity on children's attitudes and preferences for essential oils: a follow up study. Explore (NY). 2010 May-Jun;6(3):172. doi: 10.1016/j.explore.2010.02.002. No abstract available.

    PMID: 20451151BACKGROUND
  • Gardiner P, Wornham W. Recent review of complementary and alternative medicine used by adolescents. Curr Opin Pediatr. 2000 Aug;12(4):298-302. doi: 10.1097/00008480-200008000-00002.

    PMID: 10943807BACKGROUND
  • Gaul C, Eismann R, Schmidt T, May A, Leinisch E, Wieser T, Evers S, Henkel K, Franz G, Zierz S. Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia. 2009 Oct;29(10):1069-78. doi: 10.1111/j.1468-2982.2009.01841.x. Epub 2009 Apr 2.

    PMID: 19366356BACKGROUND
  • Gobel H, Schmidt G, Soyka D. Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia. 1994 Jun;14(3):228-34; discussion 182. doi: 10.1046/j.1468-2982.1994.014003228.x.

    PMID: 7954745BACKGROUND
  • Halcon LL. Aromatherapy: therapeutic applications of plant essential oils. Minn Med. 2002 Nov;85(11):42-6.

    PMID: 12498066BACKGROUND
  • Kabbouche MA, Linder SL. Acute treatment of pediatric headache in the emergency department and inpatient settings. Pediatr Ann. 2005 Jun;34(6):466-71. doi: 10.3928/0090-4481-20050601-12.

    PMID: 16018229BACKGROUND
  • Keifer D, Ulbricht C, Abrams TR, Basch E, Giese N, Giles M, DeFranco Kirkwood C, Miranda M, Woods J. Peppermint (Mentha piperita): an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother. 2007;7(2):91-143. doi: 10.1300/j157v07n02_07.

    PMID: 18285310BACKGROUND
  • Kligler B, Chaudhary S. Peppermint oil. Am Fam Physician. 2007 Apr 1;75(7):1027-30.

    PMID: 17427617BACKGROUND
  • Lee MS, Choi J, Posadzki P, Ernst E. Aromatherapy for health care: an overview of systematic reviews. Maturitas. 2012 Mar;71(3):257-60. doi: 10.1016/j.maturitas.2011.12.018. Epub 2012 Jan 27.

    PMID: 22285469BACKGROUND
  • Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S; American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents [RETIRED]: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004 Dec 28;63(12):2215-24. doi: 10.1212/01.wnl.0000147332.41993.90.

    PMID: 15623677BACKGROUND
  • Loman DG. The use of complementary and alternative health care practices among children. J Pediatr Health Care. 2003 Mar-Apr;17(2):58-63. doi: 10.1067/mph.2003.29.

    PMID: 12665727BACKGROUND
  • Martin, I. (2007). Aromatherapy for Massage Practitioners. Lippincott Williams Wilkins; Baltimore, MD.

    BACKGROUND
  • Mauskop A. Alternative therapies in headache. Is there a role? Med Clin North Am. 2001 Jul;85(4):1077-84. doi: 10.1016/s0025-7125(05)70360-6.

    PMID: 11480259BACKGROUND
  • Mosby Skills Adapted from Perry, A.G., Potter, P.A., Ostendorf, W.R. (2014). Clinical nursing skills & techniques (8th ed.). St. Louis: Mosby

    BACKGROUND
  • Nishimura M, Tatsuya Saito TS, Kato T, Onodera S. Effects of Water Temperature during Foot Bath in Young Females. Yonago Acta Med. 2013 Sep;56(3):79-80. Epub 2013 Sep 11.

    PMID: 24174706BACKGROUND
  • Peterson CC, Palermo TM. Parental reinforcement of recurrent pain: the moderating impact of child depression and anxiety on functional disability. J Pediatr Psychol. 2004 Jul-Aug;29(5):331-41. doi: 10.1093/jpepsy/jsh037.

    PMID: 15187172BACKGROUND
  • Posadzki P, Alotaibi A, Ernst E. Adverse effects of aromatherapy: a systematic review of case reports and case series. Int J Risk Saf Med. 2012 Jan 1;24(3):147-61. doi: 10.3233/JRS-2012-0568.

    PMID: 22936057BACKGROUND
  • Roth-Isigkeit A, Thyen U, Stoven H, Schwarzenberger J, Schmucker P. Pain among children and adolescents: restrictions in daily living and triggering factors. Pediatrics. 2005 Feb;115(2):e152-62. doi: 10.1542/peds.2004-0682.

    PMID: 15687423BACKGROUND
  • Saeki Y. The effect of foot-bath with or without the essential oil of lavender on the autonomic nervous system: a randomized trial. Complement Ther Med. 2000 Mar;8(1):2-7.

    PMID: 10812753BACKGROUND
  • Saeki Y, Nagai N, Hishinuma M. Effects of footbathing on autonomic nerve and immune function. Complement Ther Clin Pract. 2007 Aug;13(3):158-65. doi: 10.1016/j.ctcp.2006.12.006. Epub 2007 Feb 20.

    PMID: 17631258BACKGROUND
  • Schetzek S, Heinen F, Kruse S, Borggraefe I, Bonfert M, Gaul C, Gottschling S, Ebinger F. Headache in children: update on complementary treatments. Neuropediatrics. 2013 Feb;44(1):25-33. doi: 10.1055/s-0032-1333435. Epub 2013 Jan 11.

    PMID: 23315555BACKGROUND
  • Smith MC, Kyle L. Holistic foundations of aromatherapy for nursing. Holist Nurs Pract. 2008 Jan-Feb;22(1):3-9; quiz 10-1. doi: 10.1097/01.HNP.0000306321.03590.32.

    PMID: 18172401BACKGROUND
  • Stankewitz A, May A. Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology. 2011 Aug 2;77(5):476-82. doi: 10.1212/WNL.0b013e318227e4a8. Epub 2011 Jul 20.

    PMID: 21775739BACKGROUND
  • Szema AM, Barnett T. Allergic reaction to mint leads to asthma. Allergy Rhinol (Providence). 2011 Jan;2(1):43-5. doi: 10.2500/ar.2011.2.0008.

    PMID: 22852115BACKGROUND
  • Termine C, Ginevra OF, D'Arrigo S, Rossi M, Lanzi G. Alternative therapies in the treatment of headache in childhood, adolescence and adulthood. Funct Neurol. 2005 Jan-Mar;20(1):9-14.

    PMID: 15948561BACKGROUND
  • Tisserand, R. & Balacs, T. (1995). Essential oil safety. Edinburgh: Churchill Livingstone

    BACKGROUND
  • Tisserand, R. & Young, R. (2014). Essential Oil Safety. A Guide for Health Care Professionals (2nd edition). Elsevier

    BACKGROUND
  • von Baeyer CL. Interpreting the high prevalence of pediatric chronic pain revealed in community surveys. Pain. 2011 Dec;152(12):2683-2684. doi: 10.1016/j.pain.2011.08.023. Epub 2011 Sep 14. No abstract available.

    PMID: 21920669BACKGROUND
  • Kingsley RA. Randomized Trial Examining Efficacy of Mentha piperita in Reducing Chronic Headache Discomfort in Youth. Pain Manag Nurs. 2023 Dec;24(6):e139-e147. doi: 10.1016/j.pmn.2023.08.004. Epub 2023 Sep 18.

Related Links

MeSH Terms

Conditions

Headache DisordersMigraine DisordersHeadache

Interventions

Aromatherapy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesHeadache Disorders, PrimaryPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPhytotherapySensory Art TherapiesPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Rae A Kingsley, MSN, APRN

    Children's Mercy Hospital Kansas City

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2015

First Posted

May 12, 2015

Study Start

March 25, 2015

Primary Completion

January 4, 2017

Study Completion

January 4, 2017

Last Updated

April 10, 2017

Record last verified: 2017-04

Locations